azacitidine has been researched along with Mediastinal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruederlein, S; Färbinger, J; Gehringer, F; Guan, H; Holzmann, K; Leithäuser, F; Möller, P; Ritz, O; Ushmorov, A; Vogel, MJ; Weitzer, CD; Wirth, T; Xie, L | 1 |
1 other study(ies) available for azacitidine and Mediastinal Neoplasms
| Article | Year |
|---|---|
FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.
Topics: Apoptosis; Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; Down-Regulation; Epigenomics; Forkhead Box Protein O1; Forkhead Transcription Factors; Humans; Lymphoma, B-Cell; Mediastinal Neoplasms; Signal Transduction | 2014 |